Empowering plants for a healthier future
22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on improving health and wellness through plant science.
22nd Century Group, Inc. (Nasdaq: XXII) is a next-generation plant biotechnology company, focused on improving human health through plant science. Using our breakthrough, patent-protected IP to control nicotine biosynthesis in the tobacco plant, we have developed the first market-ready, reduced nicotine content (RNC) tobacco plants and cigarettes containing 95% less nicotine. We received the first and only FDA MRTP authorization for a combustible cigarette in December 2021. The sole function of our cigarettes is to make it easier to reduce the number of cigarettes smoked.
In tobacco, 22nd Century employs a unique and innovative platform of modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding, to deliver healthier solutions for pressing issues. We create new, proprietary plants with select alkaloid, terpenoid, and flavonoid profiles, improved yields, and valuable agronomic traits for the life science and consumer products industries.
What We Do
Cigarette Harm Reduction
Our primary mission in tobacco is to reduce the harm caused by smoking. Our VLN® reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – are the only FDA-authorized cigarette designed to help smokers reduce their intake.Read More
Years of Life Gained
Premature Deaths Avoided
Less Cigarettes Smoked Per Day